カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の乳がん診断市場2023-2030：製品別（プラットフォームベース、機器ベース）、種類別（画像診断、生検、ゲノム検査、血液検査）、用途別、エンドユーザー別、地域別

【英語タイトル】Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV057）・商品コード：GRV23NOV057
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：190
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

乳がん診断市場の成長と動向
Grand View Research Inc.の最新調査によると、世界の乳がん診断市場規模は2030年までに77億米ドルに達する見込みです。同市場は、2023年から2030年にかけて年平均成長率7.4%で拡大する見込みです。この成長は、乳がんに対する意識の高まりと相まって、乳がんのリスクと早期発見にさらされる高齢者人口の増加に起因するところが大きい。

2Dマンモグラフィよりも精度の高い3Dマンモグラフィやデジタル乳房トモシンセシスの導入が市場の成長を支えています。この先進技術は、2Dマンモグラフィよりも40.0%多くがんを検出でき、患者のリコールを減らすことができます。急速な技術の進歩は、今後数年間にわたり市場を牽引すると予想される主な要因です。

企業は、自社のリソースを新製品の開発に役立てるとともに、サプライチェーンを強化する戦略を採用しています。2019年11月には、Exact Sciences CorporationがGenomic Healthの買収を発表し、同社の製品ポートフォリオを獲得することで、市場での地位と提供サービスの強化に貢献すると期待されました。2021年1月、Hologic Inc.はBiotheranostics社を約230百万米ドルで買収することで合意したと発表。Biotheranostics社は、乳がんおよび転移性がんに対する商業段階の分子診断薬を提供する企業です。

乳がんの予測検査やコンパニオン診断検査の発売が増加しており、市場の成長が期待されています。このセグメントにおける最近の発売には、乳がんコンパニオン診断薬として2018年にFDAの承認を取得したMyriad Genetics社のBRACAnalysis CDxが含まれます。2019年5月、QIAGEN社は、組織生検やリキッド生検からの治療決定の指針となるNovartis社独自のPIQRAYのコンパニオン診断薬としてtherascreen PIK3CA RGQ PCR Kitを発表しました。

2019年1月、Fujifilm Holdings Corporationは、ASPIRE Cristalleマンモグラフィシステム用のトモシンセシス生検オプションを発表しました。この技術は、強化された3D画像とデジタルマンモグラムを提供することで、医師が他と比較してより効率的に乳がんを検出できるようになると期待されました。

しかし、これらの画像診断には特有の危険因子があります。それらは、蛍光剤やバリウム造影剤を大量に投与すること、画像診断や内視鏡検査の場合には放射線被曝を伴うことで、吐き気や下痢などの副作用を引き起こす可能性があります。CT、MRI、X線の使用に伴う電離放射線被ばくのリスクや、PETにおける放射性トレーサー注射の使用は、このようなスクリーニング方法の採用を制限する可能性があります。したがって、画像診断の副作用などの要因は、この市場の企業にとって課題となっています。

乳がん診断市場レポートハイライト

- 2022年の収益シェアは画像診断分野が最大で、血液検査分野が最速で成長する見込みです。

- 製品別では、米国、カナダ、英国などの先進国で45歳以上の女性に対する検診が義務化され、乳がんの検査や検診が全体的に増加しているなどの政府の取り組みにより、機器ベースの製品分野が2022年に最大の収益シェアを獲得しました。

- 予測期間中、最も急成長が見込まれるのはプラットフォームベースの製品セグメントです。これらの検査は、主に女性における化学療法や標的療法の有効性を評価するために使用されます。

- アプリケーション別では、診断・予知セグメントが2022年の市場を支配し、診断の進歩に向けた共同研究や取り組みの増加により、予後セグメントが予測期間で最も速いCAGRを記録すると予測されます。

- 2022年の市場は病院・診療所市場が支配しました。

- 医療ラボおよび診断センター分野は、NGSやPCRのようなプラットフォームベースの検査の増加により、予測期間中に最も速いCAGRを目撃することが予想されます。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 世界の乳がん診断市場変数・傾向・範囲
第4章 世界の乳がん診断市場：種類別予測・傾向分析
第5章 世界の乳がん診断市場：製品別予測・傾向分析
第6章 世界の乳がん診断市場：用途別予測・傾向分析
第7章 世界の乳がん診断市場：エンドユーザー別予測・傾向分析
第8章 世界の乳がん診断市場：地域別予測・傾向分析
第9章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Product
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Product outlook
2.2.3. Application outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Breast Cancer Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Breast Cancer Diagnostics Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Breast Cancer Diagnostics: Type Estimates & Trend Analysis
4.1. Breast Cancer Diagnostics Market, Key Takeaways
4.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Imaging
4.3.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Biopsy
4.4.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Genomic Tests
4.5.1. Genomic tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Blood Tests
4.6.1. Blood tests market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Others
4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Breast Cancer Diagnostics: Product Estimates & Trend Analysis
5.1. Breast Cancer Diagnostics Market, Key Takeaways
5.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Platform-based Products
5.3.1. Platform-based products market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.1. Next-generation sequencing
5.3.1.1.1. Next-generation sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.2. Microarrays
5.3.1.2.1. Microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.3. PCR
5.3.1.3.1. PCR market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.1.4. Others
5.3.1.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Instruments-based Products
5.4.1. Instruments-based products market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.1.1. Imaging
5.4.1.1.1. Imaging market estimates and forecasts, 2018 to 2030 (USD Million)
5.4.1.2. Biopsy
5.4.1.2.1. Biopsy market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Breast Cancer Diagnostics: Application Estimates & Trend Analysis
6.1. Breast Cancer Diagnostics Market, Key Takeaways
6.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Screening
6.3.1. Screening market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Diagnostic and Predictive
6.4.1. Diagnostic and predictive market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Prognostic
6.5.1. Prognostic market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Research
6.6.1. Research market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Breast Cancer Diagnostics: End-use Estimates & Trend Analysis
7.1. Breast Cancer Diagnostics Market, Key Takeaways
7.2. Breast Cancer Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals & Clinics
7.3.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Diagnostic Centers and Medical Laboratories
7.4.1. Diagnostic centers and medical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Others
7.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Breast Cancer Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Breast Cancer Diagnostics Market by Region: Key Takeaway
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Hologic Inc.
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product Benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Genomic Health (Exact Sciences Corporation)
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. BD
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Danaher
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Koninklijke Philips N.V.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. QIAGEN
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Thermo Fisher Scientific Inc.
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Myriad Genetics, Inc.
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Argon Medical Devices, Inc.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. F. Hoffmann-La Roche Ltd.
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviation
Table 2 North America breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 3 North America breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 4 North America breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 5 North America breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 6 North America breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 8 U.S. breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 9 U.S. breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 10 U.S. breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 12 Canada breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 13 Canada breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 14 Canada breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 16 Europe breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 17 Europe breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 18 Europe breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 20 Germany breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 21 Germany breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 22 Germany breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 23 Germany breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 24 UK breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 25 UK breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 26 UK breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 27 UK breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 28 France breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 29 France breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 30 France breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 31 France breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 32 Italy breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 33 Italy breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 34 Italy breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 35 Italy breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 36 Spain breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 37 Spain breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 38 Spain breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 39 Spain breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 40 Sweden breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 41 Sweden breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 42 Sweden breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 44 Norway breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 45 Norway breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 46 Norway breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 47 Norway breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 48 Denmark breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 49 Denmark breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 50 Denmark breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 51 Denmark breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 52 Asia Pacific breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 53 Asia Pacific breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 54 Asia Pacific breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 55 Asia Pacific breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 56 Asia Pacific breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 57 Japan breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 58 Japan breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 59 Japan breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 60 Japan breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 61 China breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 62 China breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 63 China breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 64 China breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 65 India breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 66 India breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 67 India breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 68 India breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 69 Australia breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 70 Australia breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 71 Australia breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 72 Australia breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 73 Thailand breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 74 Thailand breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 75 Thailand breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 76 Thailand breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 77 South Korea breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 78 South Korea breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 79 South Korea breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 80 South Korea breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 81 Latin America breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 82 Latin America breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 83 Latin America breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 84 Latin America breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 85 Latin America breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 87 Brazil breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 88 Brazil breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 89 Brazil breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 90 Mexico breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 91 Mexico breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 92 Mexico breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 93 Mexico breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 94 Argentina breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 95 Argentina breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 96 Argentina breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 97 Argentina breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa breast cancer diagnostics market, by region, 2018 - 2030 (USD Million)
Table 103 Saudi Arabia breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 104 Saudi Arabia breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 105 Saudi Arabia breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 106 Saudi Arabia breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 107 South Africa breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 108 South Africa breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 109 South Africa breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 110 South Africa breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 111 UAE breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 112 UAE breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 113 UAE breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 114 UAE breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 115 Kuwait breast cancer diagnostics market, by type, 2018 - 2030 (USD Million)
Table 116 Kuwait breast cancer diagnostics market, by product, 2018 - 2030 (USD Million)
Table 117 Kuwait breast cancer diagnostics market, by application, 2018 - 2030 (USD Million)
Table 118 Kuwait breast cancer diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Breast cancer diagnostics: Market outlook
Fig. 9 Breast cancer diagnostics: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Breast cancer diagnostics market driver impact
Fig. 15 Breast cancer diagnostics market restraint impact
Fig. 16 Breast cancer diagnostics strategic initiatives analysis
Fig. 17 Breast cancer diagnostics market: Type movement analysis
Fig. 18 Breast cancer diagnostics market: Type outlook and key takeaways
Fig. 19 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Genomic tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Blood tests market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Breast cancer diagnostics market: Product movement analysis
Fig. 25 Breast cancer diagnostics market: Product outlook and key takeaways
Fig. 26 Platform based products market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Next-generation sequencing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Instruments-based products market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Imaging market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Biopsy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Breast cancer diagnostics market: Application movement analysis
Fig. 34 Breast cancer diagnostics market: Application outlook and key takeaways
Fig. 35 Screening market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Diagnostic and predictive market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Prognostic market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Breast cancer diagnostics market: End-use movement analysis
Fig. 40 Breast cancer diagnostics market: End-use outlook and key takeaways
Fig. 41 Hospitals & clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Diagnostic centers and medical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Global breast cancer diagnostics market: Regional movement analysis
Fig. 45 Global breast cancer diagnostics market: Regional outlook and key takeaways
Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

★調査レポート[世界の乳がん診断市場2023-2030：製品別（プラットフォームベース、機器ベース）、種類別（画像診断、生検、ゲノム検査、血液検査）、用途別、エンドユーザー別、地域別] (コード：GRV23NOV057)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の乳がん診断市場2023-2030：製品別（プラットフォームベース、機器ベース）、種類別（画像診断、生検、ゲノム検査、血液検査）、用途別、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の卵巣がん診断市場2023-2030：診断種類別（画像診断、血液検査、生検、その他）、がん種類別（上皮性腫瘍、間質細胞腫瘍、胚細胞腫瘍、その他）、エンドユーザー別（病院研究所、がん診断センター、研究機関、その他）、地域別
  • 世界の肝疾患診断市場2024-2030：診断技術別（画像診断、臨床検査、内視鏡検査、生検、その他）、エンドユーザー別（病院、研究所、その他）、地域別
  • 世界の膵臓がん診断市場2023-2030：製品別、検査種類別（イメージング検査、生検、血液検査、その他）、がん種類別（外分泌、内分泌）、エンドユーザー別、地域別
  • 世界の腎機能検査市場2023-2030：製品別（クリアランス検査、血液検査、尿検査、希釈・濃縮検査薬、その他）、エンドユーザー別、地域別
  • 世界の子癇前症診断市場2022-2029：検査種類別（血液検査、尿分析）、製品別（機器、消耗品）、エンドユーザー別（病院、専門クリニック、診断センター、その他）、地域別
  • 世界の動脈硬化治療薬市場2023-2030：ステージ別（内皮障害＆免疫反応、ファットストリーク、プラーク成長、プラーク破裂）、診断別（足首上腕指数、ドップラー超音波、心エコー、心電図、血液検査、その他）、治療法別（投薬、手術、その他）、投与経路別（経口、非経口、その他）、エンドユーザー別（病院、専門クリニック、在宅医療、その他）、流通チャネル別（病院薬局、小売薬局、オンライン薬局、その他）、地域別
  • 世界のがん診断におけるAI市場2023-2030：コンポーネント別、がん種類別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆